News | December 12, 2022
Entod Pharmaceuticals to launch GLO division
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
The company is moving towards complex and more differentiated products
The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA
Subscribe To Our Newsletter & Stay Updated
